Physician profile
Katherine Dowell
NPI 1124684550
$420.32
in general payments reported to CMS, 2019-2025
12 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $299 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $98.91 | 2024-2025 | Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $63.05 | 2024-2025 | Cologuard Collection Kit |
| Amgen INC. | $54.80 | 2024-2025 | Otezla, Repatha, Evenity |
| Merck Sharp & Dohme LLC | $37.67 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Astrazeneca Pharmaceuticals Lp | $29.27 | 2024-2025 | Airsupra, Farxiga |
| Phathom Pharmaceuticals, INC. | $26.12 | 2024 | Voquezna |
| Pfizer INC. | $23.35 | 2024 | |
| Gilead Sciences, INC. | $20.07 | 2024 | Epclusa |
| Novo Nordisk INC | $18.45 | 2024 | Rybelsus, Ozempic |
| Sanofi Pasteur INC. | $18.16 | 2025 | |
| Irhythm Technologies, INC. | $15.38 | 2024 | Zio Xt Patch, Zio Monitor |
| Abbvie INC. | $15.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Dowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.